Oncology Institute (TOI) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to -$0.14.
- Oncology Institute's EPS (Weighted Average and Diluted) rose 2222.22% to -$0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.65, marking a year-over-year increase of 1666.67%. This contributed to the annual value of -$0.71 for FY2024, which is 2325.78% up from last year.
- As of Q3 2025, Oncology Institute's EPS (Weighted Average and Diluted) stood at -$0.14, which was up 2222.22% from -$0.15 recorded in Q2 2025.
- In the past 5 years, Oncology Institute's EPS (Weighted Average and Diluted) ranged from a high of $0.21 in Q1 2022 and a low of -$0.33 during Q1 2023
- In the last 5 years, Oncology Institute's EPS (Weighted Average and Diluted) had a median value of -$0.15 in 2025 and averaged -$0.13.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 22167862155.53% in 2021, then skyrocketed by 115000.0% in 2022.
- Oncology Institute's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.15 in 2021, then increased by 8.96% to -$0.14 in 2022, then crashed by 86.22% to -$0.25 in 2023, then soared by 43.27% to -$0.14 in 2024, then rose by 2.95% to -$0.14 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.14 for Q3 2025, versus -$0.15 for Q2 2025 and -$0.21 for Q1 2025.